UCB SA (UNC.DE) Fundamental Analysis & Valuation

FRA:UNC • BE0003739530

Current stock price

251.8 EUR
-3.2 (-1.25%)
Last:

This UNC.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. UNC.DE Profitability Analysis

1.1 Basic Checks

  • UNC had positive earnings in the past year.
  • UNC had a positive operating cash flow in the past year.
  • UNC had positive earnings in each of the past 5 years.
  • Each year in the past 5 years UNC had a positive operating cash flow.
UNC.DE Yearly Net Income VS EBIT VS OCF VS FCFUNC.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

1.2 Ratios

  • The Return On Assets of UNC (8.58%) is better than 64.71% of its industry peers.
  • UNC's Return On Equity of 14.34% is in line compared to the rest of the industry. UNC outperforms 58.82% of its industry peers.
  • With a Return On Invested Capital value of 10.29%, UNC perfoms like the industry average, outperforming 58.82% of the companies in the same industry.
  • UNC had an Average Return On Invested Capital over the past 3 years of 5.76%. This is significantly below the industry average of 14.61%.
  • The 3 year average ROIC (5.76%) for UNC is below the current ROIC(10.29%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.58%
ROE 14.34%
ROIC 10.29%
ROA(3y)5.64%
ROA(5y)5.4%
ROE(3y)9.59%
ROE(5y)9.2%
ROIC(3y)5.76%
ROIC(5y)5.83%
UNC.DE Yearly ROA, ROE, ROICUNC.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10

1.3 Margins

  • UNC has a Profit Margin of 20.13%. This is in the better half of the industry: UNC outperforms 76.47% of its industry peers.
  • UNC's Profit Margin has improved in the last couple of years.
  • UNC has a better Operating Margin (25.98%) than 66.67% of its industry peers.
  • In the last couple of years the Operating Margin of UNC has grown nicely.
  • UNC's Gross Margin of 74.29% is fine compared to the rest of the industry. UNC outperforms 68.63% of its industry peers.
  • In the last couple of years the Gross Margin of UNC has remained more or less at the same level.
Industry RankSector Rank
OM 25.98%
PM (TTM) 20.13%
GM 74.29%
OM growth 3Y27.72%
OM growth 5Y4.58%
PM growth 3Y38.49%
PM growth 5Y8.01%
GM growth 3Y2.17%
GM growth 5Y-0.06%
UNC.DE Yearly Profit, Operating, Gross MarginsUNC.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. UNC.DE Health Analysis

2.1 Basic Checks

  • UNC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, UNC has about the same amount of shares outstanding.
  • The number of shares outstanding for UNC has been increased compared to 5 years ago.
  • Compared to 1 year ago, UNC has an improved debt to assets ratio.
UNC.DE Yearly Shares OutstandingUNC.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
UNC.DE Yearly Total Debt VS Total AssetsUNC.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 5.62 indicates that UNC is not in any danger for bankruptcy at the moment.
  • UNC's Altman-Z score of 5.62 is amongst the best of the industry. UNC outperforms 82.35% of its industry peers.
  • UNC has a debt to FCF ratio of 1.22. This is a very positive value and a sign of high solvency as it would only need 1.22 years to pay back of all of its debts.
  • UNC has a Debt to FCF ratio of 1.22. This is amongst the best in the industry. UNC outperforms 88.24% of its industry peers.
  • A Debt/Equity ratio of 0.20 indicates that UNC is not too dependend on debt financing.
  • The Debt to Equity ratio of UNC (0.20) is better than 72.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.22
Altman-Z 5.62
ROIC/WACC1.29
WACC7.95%
UNC.DE Yearly LT Debt VS Equity VS FCFUNC.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.3 Liquidity

  • UNC has a Current Ratio of 1.38. This is a normal value and indicates that UNC is financially healthy and should not expect problems in meeting its short term obligations.
  • UNC's Current ratio of 1.38 is in line compared to the rest of the industry. UNC outperforms 47.06% of its industry peers.
  • A Quick Ratio of 1.04 indicates that UNC should not have too much problems paying its short term obligations.
  • UNC has a Quick ratio (1.04) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 1.04
UNC.DE Yearly Current Assets VS Current LiabilitesUNC.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. UNC.DE Growth Analysis

3.1 Past

  • UNC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 100.60%, which is quite impressive.
  • Measured over the past years, UNC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 13.26% on average per year.
  • Looking at the last year, UNC shows a very strong growth in Revenue. The Revenue has grown by 25.83%.
  • Measured over the past years, UNC shows a small growth in Revenue. The Revenue has been growing by 7.68% on average per year.
EPS 1Y (TTM)100.6%
EPS 3Y31.73%
EPS 5Y13.26%
EPS Q2Q%123.53%
Revenue 1Y (TTM)25.83%
Revenue growth 3Y11.95%
Revenue growth 5Y7.68%
Sales Q2Q%26.57%

3.2 Future

  • The Earnings Per Share is expected to grow by 16.75% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 10.92% on average over the next years. This is quite good.
EPS Next Y2.96%
EPS Next 2Y15.35%
EPS Next 3Y17.69%
EPS Next 5Y16.75%
Revenue Next Year11.84%
Revenue Next 2Y12.38%
Revenue Next 3Y12.24%
Revenue Next 5Y10.92%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
UNC.DE Yearly Revenue VS EstimatesUNC.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B
UNC.DE Yearly EPS VS EstimatesUNC.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

3

4. UNC.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 25.21 indicates a quite expensive valuation of UNC.
  • UNC's Price/Earnings ratio is in line with the industry average.
  • UNC is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.23, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 24.48, the valuation of UNC can be described as rather expensive.
  • The rest of the industry has a similar Price/Forward Earnings ratio as UNC.
  • UNC's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.51.
Industry RankSector Rank
PE 25.21
Fwd PE 24.48
UNC.DE Price Earnings VS Forward Price EarningsUNC.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • UNC's Enterprise Value to EBITDA is on the same level as the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of UNC is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 26.59
EV/EBITDA 18.33
UNC.DE Per share dataUNC.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • UNC has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as UNC's earnings are expected to grow with 17.69% in the coming years.
PEG (NY)8.52
PEG (5Y)1.9
EPS Next 2Y15.35%
EPS Next 3Y17.69%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. UNC.DE Dividend Analysis

5.1 Amount

  • UNC has a yearly dividend return of 0.39%, which is pretty low.
  • UNC's Dividend Yield is comparable with the industry average which is at 1.90.
  • Compared to an average S&P500 Dividend Yield of 1.90, UNC's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.39%

5.2 History

  • The dividend of UNC has a limited annual growth rate of 2.20%.
Dividend Growth(5Y)2.2%
Div Incr YearsN/A
Div Non Decr YearsN/A
UNC.DE Yearly Dividends per shareUNC.DE Yearly Dividends per shareYearly Dividends per share 2026 0.5 1

5.3 Sustainability

  • UNC pays out 16.94% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of UNC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP16.94%
EPS Next 2Y15.35%
EPS Next 3Y17.69%
UNC.DE Yearly Income VS Free CF VS DividendUNC.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
UNC.DE Dividend Payout.UNC.DE Dividend Payout, showing the Payout Ratio.UNC.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

UNC.DE Fundamentals: All Metrics, Ratios and Statistics

UCB SA

FRA:UNC (3/26/2026, 7:00:00 PM)

251.8

-3.2 (-1.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-26
Earnings (Next)07-21
Inst Owners40.45%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap48.98B
Revenue(TTM)7.74B
Net Income(TTM)1.56B
Analysts75.56
Price Target283.04 (12.41%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.39%
Yearly Dividend1.39
Dividend Growth(5Y)2.2%
DP16.94%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.51%
PT rev (3m)11.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.02%
EPS NY rev (3m)0.6%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.32%
Revenue NY rev (3m)1.32%
Valuation
Industry RankSector Rank
PE 25.21
Fwd PE 24.48
P/S 6.33
P/FCF 26.59
P/OCF 21.38
P/B 4.51
P/tB 21.03
EV/EBITDA 18.33
EPS(TTM)9.99
EY3.97%
EPS(NY)10.29
Fwd EY4.08%
FCF(TTM)9.47
FCFY3.76%
OCF(TTM)11.78
OCFY4.68%
SpS39.8
BVpS55.87
TBVpS11.97
PEG (NY)8.52
PEG (5Y)1.9
Graham Number112.06
Profitability
Industry RankSector Rank
ROA 8.58%
ROE 14.34%
ROCE 14.62%
ROIC 10.29%
ROICexc 12.64%
ROICexgc 53.22%
OM 25.98%
PM (TTM) 20.13%
GM 74.29%
FCFM 23.8%
ROA(3y)5.64%
ROA(5y)5.4%
ROE(3y)9.59%
ROE(5y)9.2%
ROIC(3y)5.76%
ROIC(5y)5.83%
ROICexc(3y)6.83%
ROICexc(5y)6.79%
ROICexgc(3y)30.47%
ROICexgc(5y)36.26%
ROCE(3y)8.18%
ROCE(5y)8.29%
ROICexgc growth 3Y18.32%
ROICexgc growth 5Y-5.98%
ROICexc growth 3Y44.94%
ROICexc growth 5Y7.84%
OM growth 3Y27.72%
OM growth 5Y4.58%
PM growth 3Y38.49%
PM growth 5Y8.01%
GM growth 3Y2.17%
GM growth 5Y-0.06%
F-Score9
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.22
Debt/EBITDA 0.83
Cap/Depr 71.61%
Cap/Sales 5.8%
Interest Coverage 15.71
Cash Conversion 86.85%
Profit Quality 118.23%
Current Ratio 1.38
Quick Ratio 1.04
Altman-Z 5.62
F-Score9
WACC7.95%
ROIC/WACC1.29
Cap/Depr(3y)55.86%
Cap/Depr(5y)76.64%
Cap/Sales(3y)5.68%
Cap/Sales(5y)6.46%
Profit Quality(3y)111.45%
Profit Quality(5y)122.7%
High Growth Momentum
Growth
EPS 1Y (TTM)100.6%
EPS 3Y31.73%
EPS 5Y13.26%
EPS Q2Q%123.53%
EPS Next Y2.96%
EPS Next 2Y15.35%
EPS Next 3Y17.69%
EPS Next 5Y16.75%
Revenue 1Y (TTM)25.83%
Revenue growth 3Y11.95%
Revenue growth 5Y7.68%
Sales Q2Q%26.57%
Revenue Next Year11.84%
Revenue Next 2Y12.38%
Revenue Next 3Y12.24%
Revenue Next 5Y10.92%
EBIT growth 1Y40.24%
EBIT growth 3Y42.99%
EBIT growth 5Y12.61%
EBIT Next Year62.5%
EBIT Next 3Y32.86%
EBIT Next 5Y25.36%
FCF growth 1Y100.22%
FCF growth 3Y35.04%
FCF growth 5Y20.27%
OCF growth 1Y84.46%
OCF growth 3Y26.98%
OCF growth 5Y16.21%

UCB SA / UNC.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for UCB SA?

ChartMill assigns a fundamental rating of 6 / 10 to UNC.DE.


What is the valuation status of UCB SA (UNC.DE) stock?

ChartMill assigns a valuation rating of 3 / 10 to UCB SA (UNC.DE). This can be considered as Overvalued.


Can you provide the profitability details for UCB SA?

UCB SA (UNC.DE) has a profitability rating of 7 / 10.


What is the valuation of UCB SA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for UCB SA (UNC.DE) is 25.21 and the Price/Book (PB) ratio is 4.51.


Can you provide the financial health for UNC stock?

The financial health rating of UCB SA (UNC.DE) is 7 / 10.